Login / Signup

Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patients.

Hyung Joon YimWon KimSang Hoon AhnYoung-Kul JungSoon Ho UmJoo Hyun SohnJae Young JangDong Joon KimEun-Sook ParkSo-Young JinKyun-Hwan Kim
Published in: Journal of gastroenterology and hepatology (2021)
The BSV therapy improves hepatic histology and decreases intrahepatic cccDNA in CHB patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • hepatitis b virus
  • mesenchymal stem cells
  • cell free
  • liver fibrosis
  • nucleic acid